Evidence map›Paper›PMID 41245382›Full record

ReviewOpen life sciences2025

Efficacy and mechanism of escin in improving the tissue microenvironment of blood vessel walls via anti-inflammatory and anticoagulant effects: Implications for clinical practice.

Linyin Yan, Yu Zhang, Yanqiang Li, Decai Dai, Jianjun Zhu, Yue Chen, Wei Xiao

Abstract readReview
In one paragraph

Review in Open life sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Linyin YanDepartment of Chemical and Materials Engineering, Hainan Vocational University of Science and Technology, Haikou, Hainan, 57010, China.
Yu ZhangDepartment of Chemical and Materials Engineering, Hainan Vocational University of Science and Technology, Haikou, Hainan, 57010, China.
Yanqiang LiDepartment of Chemical and Materials Engineering, Hainan Vocational University of Science and Technology, Haikou, Hainan, 57010, China.
Decai DaiDepartment of Chemical and Materials Engineering, Hainan Vocational University of Science and Technology, Haikou, Hainan, 57010, China.
Jianjun ZhuState Key Laboratory of NBC Protection for Civilian, Research Institute of Chemical Defense, Academy of Military Science, Beijing, 102205, China.
Yue ChenEconomic and Technological Development Zone, Yantai Haisen Big Data Co., Ltd, No. 48, Nanchang Street, Yantai, Shandong, 265500, People's Republic of China.
Wei XiaoWuhan Aimin Pharmaceutical Co., LTD, Wuhan, Hubei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Escin, a natural medicinal saponin, has garnered significant attention in recent years for its pharmacological effects in various diseases. Though the structure and pharmacodynamic targets of escin are documented, reviews on its efficacy and mechanisms were still mainly from the clinical application perspective at the organ level or animal models. Deeper discussion at the tissue microenvironment level remains sparse, as the sophisticated cell and molecular technique is required. Contradictory conclusion might occur if such experiment setups are not carefully distinguished. This article reviews and analyzes literature to discuss escin's ability to improve the tissue microenvironment of blood vessel walls and elucidates the underlying mechanisms. Escin demonstrates significant anti-inflammatory properties and neutralizes free radicals, thereby protecting vascular endothelial cells from oxidative stress. Additionally, escin's anticoagulant properties reduce blood viscosity, preventing clot formation and maintaining vessel patency. These mechanisms collectively enhance the tissue microenvironment of blood vessel walls and promote cardiovascular health, which provides a multi-target therapeutic strategy for cardiovascular diseases (CVD), integrating anti-inflammatory, antioxidant, endothelial repair, and microcirulation-enhancing mechanisms, consistent with current pathophysiological insights. The article also addresses the current research status, challenges, and future potential of escin in vascular protection, offering new perspectives and strategies for CVD treatment and prevention.

Indexed as

anti-inflammatoryantioxidantescinmicroenvironmentvascular protection

Identifiers

PMID41245382
PMCPMC12619636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.